Xeris Pharmaceuticals xerispharma.com


Public list: BIO 2016 (619) Medical Devices (6162) Pharma Startups (6570) Neuroscience Startups (947)

Xeris is a specialty biopharmaceutical company focused on developing improved and differentiated injectable therapeutics for multiple indications in diabetes, epilepsy, and immunology. The company's XeriSol and XeriJect formulation technologies allow for the subcutaneous and intradermal delivery of highly concentrated, non-aqueous, ready-to-use formulations of peptides, proteins, antibodies, and small molecules using auto-injectors, multi-dose pens, and pumps. Xeris' formulation platforms have ...Show all

Xeris is a specialty biopharmaceutical company focused on developing improved and differentiated injectable therapeutics for multiple indications in diabetes, epilepsy, and immunology. The company's XeriSol and XeriJect formulation technologies allow...Show all

Company (IPO / Went public)

All investors data 19 Investors

Phone: 844-445-5704

Fax:

180 N LaSalle St
Suite 1800
 Chicago, 60601
 Illinois, United States

Latest News

See more competitors data Competitors
Total Funding Date of Last Funding
Xeris Pharmaceuticals $153.6M Jun 21, 2018

Web Traffic

Rank

Show (-10)

Engagement (PVPU)

Show (+1%)

Domain Authority Score
Show
Page Views Per Million (PVPM)
Show
Reach Per Million
Show

SEO Statistics

Domain Authority Score Show
Page Authority Score Show
No. External Links Show
No. Links Show

Web Traffic Statistics - Growth

Per Week Per Month Per 6 Months Per Year
Rank Login to see details
Page Views Per Million Login to see details
Page Views Per User Login to see details
Reach Per Million Login to see details

Related Xeris Pharmaceuticals Jobs

jobs by Indeed job search

Investors

Investor Investor Type Location Participating Rounds
See all 19 investors

Board Members

Name Firm
Login to see detailsRedmile Group
Login to see detailsPalmetto Partners
Login to see detailsIdanta Partners
Login to see detailsHorizon Therapeutics
There is no Competitors data available for this company. Please select another tab.

Patents

Title Application Date Patent Date Status
(Patent / Application)
Stable formulations for parenteral injection of small molecule drugs Jul 29, 2015 Sep 08, 2020 Patent
Methods for producing stable therapeutic formulations in aprotic polar solvents May 15, 2017 Nov 26, 2019 Patent
Stable glucagon formulations for the treatment of hypoglycemia Feb 21, 2014 Jun 27, 2017 Patent
Methods for producing stable therapeutic formulations in aprotic polar solvents Apr 22, 2016 May 16, 2017 Patent
Compositions for rapidly treating severe hypoglycemia Apr 01, 2015 May 09, 2017 Patent
See all 27 patents